Tuesday, December 3, 2019

Strides Pharma gets tentative nod from USFDA for pain relieving drug

Strides Pharma Global Pte Ltd, Singapore, has received tentative
approval for Diclofenac Potassium Softgel Capsules, 25 mg from the
United States Food & Drug Administration (USFDA), Strides Pharma
Science said in a regulatory filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-gets-tentative-nod-from-usfda-for-pain-relieving-drug/articleshow/72361157.cms

No comments:

Post a Comment